Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
35 hedge funds and large institutions have $40.6M invested in Ocean Biomedical, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
106% more funds holding
Funds holding: 17 → 35 (+18)
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less capital invested
Capital invested by funds: $47.6M → $40.6M (-$6.99M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.55M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.01M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$879K |
| 4 |
State Street
Boston,
Massachusetts
|
+$720K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$396K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCFM
Cohen & Co Financial Management
New York
|
-$8.52M |
| 2 |
HF
HRT Financial
New York
|
-$389K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$221K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$201K |
| 5 |
Millennium Management
New York
|
-$189K |
OCEA Hedge Fund Activity: Q2 2023 in Review
35 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q2 2023, worth a combined $40.6M — down 15% from $47.6M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new OCEA positions and 5 closed out — a net gain of 18 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $2.55M. The largest seller was Cohen & Co Financial Management, cutting an estimated $8.52M.
- 35 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q2 2023, up from 17 in Q1 2023.
- Funds reported $40.6M of Ocean Biomedical, Inc. Common Stock stock for Q2 2023, down 15% quarter-over-quarter.
- 23 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q2 2023 and 5 closed out, a net change of +18 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q2 2023 was BlackRock, an estimated $2.55M added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q2 2023 was Cohen & Co Financial Management, an estimated $8.52M sold.
Based on aggregated 13F filings for Q2 2023.